Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2020-2029 (Includes COVID-19 Business Impact)

  • TBI995906
  • August 25, 2020
  • Global
  • 132 pages
  • ROIF Expert
                                          

We have updated Colorectal Cancer Therapeutics Market with respect to COVID-19 Business Impact. Inquire before buying This report focuses on the Colorectal Cancer Therapeutics market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Colorectal Cancer Therapeutics market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.

Global Colorectal Cancer Therapeutics Market: Segment Analysis

The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.

Global Colorectal Cancer Therapeutics Market: Regional Analysis

The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.

Global Colorectal Cancer Therapeutics Market: Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.

List of Companies Profiled

Market Players like Genentech, Inc., Merck Sharp & Dohme Corp., and Bristol Myers Squibb to Strengthen Market Position The global colorectal cancer therapeutics market is dominated by some key companies such as Genentech, Inc., Bristol Myers Squibb, and Merck due to their strong oncology product portfolio, robust pipeline candidates, and key strategic decisions. These include a group of 5-6 key companies with wider geographic presence and continued R&D resulting in strong regulatory approvals. In the same instance, a number of other companies are also present in the market. The global market has a strong scope of growth, has a heavy presence of generics especially for chemotherapy, and is subject to a number of biosimilars launches.

List Of Key Companies Profiled:

  • Genentech, Inc.
  • Eli Lilly and Company
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Bristol Myers Squibb
  • Sanofi
  • Merck Sharp & Dohme Corp.
  • Taiho Pharmaceutical (Otsuka Pharmaceutical Co., Ltd.)
  • Bayer AG
  • Regeneron Pharmaceuticals, Inc.
  • Novartis AG
  • Ipsen Biopharmaceuticals, Inc.

REPORT COVERAGE

An Infographic Representation of Colorectal Cancer Therapeutics Market View Full Infographic To get information on various segments, share your queries with us The high prevalence of colorectal cancer, strong and advanced product launches, and robust pipeline candidates is expected to increase the global colorectal cancer medications market growth. Along with this, the report provides an extensive analysis of the global market dynamics and competitive landscape and scenario. Various key insights presented in the report are the prevalence of colorectal cancer - by key countries, 2018, pipeline analysis, key industry developments, new product launches, the regulatory scenario in key countries, and increasing R&D initiatives in colorectal cancer diagnostics. Moreover, other key insights include key strategies adopted by market leaders, competitive landscape, and company profiles.

Report Scope & Segmentation

 

Segmentation

By Therapy

  • Targeted Therapy
  • Immunotherapy
  • Chemotherapy
  • Others

By Cancer Type

  • Colorectal Adenocarcinoma
  • Gastrointestinal Carcinoid Tumors
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

INDUSTRY DEVELOPMENT:

July 2019

: One of the key market players in the colorectal cancer treatment market, Pfizer completed the acquisition of Array BioPharma Inc., a key market player with a strong and robust oncology pipeline.

July 2019

: Amgen and Allergan Launch Mvasi and Kanjinti, the First Anticancer Biosimilars, in the U.S., which is utilized for the treatment of colorectal cancer.

July 2018

: The Food and Drug Administration (FDA) announced the granting of accelerated approval to ipilimumab (Yervoy) for usage in combination with nivolumab (Opdivo) for the treatment of metastatic colorectal cancer.  

Table of Content
Chapter 1. Methodology and Scope 
1.1. Research Methodology 
1.2. Research Scope & Assumptions 
1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. Colorectal Cancer Therapeutics Market
3.1. Market Segmentation 
3.2. Market Size and Growth Prospects, 2019 - 2029 
3.3. Value Chain Analysis 
3.4. Market Dynamics 
3.4.1. Market driver analysis 
3.4.2. Market restraint analysis
Chapter 4. Market Size by Application
4.1 Colorectal Cancer Therapeutics Market Consumption by Application (2015-2020) 
4.2 Colorectal Cancer Therapeutics Market Consumption by Application (2020-2029) 

|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form